TickerFactsScreenerDevelopers

HERON THERAPEUTICS, INC. /DE/ (HRTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$10.24M2010: -$9.93M2011: -$11.06M2012: -$23.83M2013: -$54.46M2014: -$74.56M2015: -$96.92M2016: -$170.91M2017: -$194.56M2018: -$183.94M2019: -$210.69M2020: -$228.16M2021: -$217.83M2022: -$174.66M2023: -$110.61M2024: -$11.53M2025: -$2.54M-$2.54M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$2.54M+78.0%
2024-$11.53M+89.6%
2023-$110.61M+36.7%
2022-$174.66M+19.8%
2021-$217.83M+4.5%
2020-$228.16M-8.3%
2019-$210.69M-14.5%
2018-$183.94M+5.5%
2017-$194.56M-13.8%
2016-$170.91M-76.3%
2015-$96.92M-30.0%
2014-$74.56M-36.9%
2013-$54.46M-128.5%
2012-$23.83M-115.4%
2011-$11.06M-11.4%
2010-$9.93M+3.0%
2009-$10.24M—